NYU Langone Health: Prostatic Neoplasms trials

The registry lists 34 Prostatic Neoplasms studies with NYU Langone Health as lead sponsor. 11 are open to participants now and 7 have results posted.

Phase 1 7Phase 2 7Phase 3 1No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SURPASS: Stereotactic Ultra-hypofractionated Radiotherapy for Post-prostatectomy Patients: Adaptive Salvage SBRTNot yet recruitingNCT07888283Not applicable
• Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate CancerRecruitingNCT07801664Phase 2
• Sexual Health Communication Skills Training Intervention for Patients With Prostate CancerNot yet recruitingNCT07655557Not applicable
• Perspectives About Online InformationNot yet recruitingNCT07631858Not applicable
• Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)RecruitingNCT07567027Not applicable
• Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU AblationRecruitingNCT07203482
• PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused UltrasoundRecruitingNCT07184970
• Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate CancerRecruitingNCT07184957
• Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyRecruitingNCT06542757Not applicable
• ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate CancerRecruitingNCT06397703Phase 2
• Two Fraction Prostate SBRT With DIL SIBRecruitingNCT05864196Phase 1
• Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical ProstatectomyActive, not recruitingNCT05678322Phase 3Results posted
• A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1TerminatedNCT03837353Phase 1/2Results posted
• Trial of Community Health Worker-led Decision CoachingCompletedNCT03726320Not applicableResults posted
• Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate CancerTerminatedNCT03366792Not applicableResults posted
• Metformin Prostate Cancer Adjuvant TrialCompletedNCT02176161Phase 2Results posted
• Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After CastrationCompletedNCT00878436Phase 1/2Results posted
• Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate CancerTerminatedNCT00861471Phase 1/2Results posted
• Randomized Trial of Trust in Online Videos About Prostate CancerCompletedNCT05886751Not applicable
• Sleep, Exercise, Nutrition and Survivorship in Prostate CancerCompletedNCT05318131Not applicable
• Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)CompletedNCT04009083Not applicable
• Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality ModelsCompletedNCT03656822
• PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted BiopsyCompletedNCT03635866Not applicable
• Investigating and Characterizing the Immune Response to Prostate CancerCompletedNCT03331367Not applicable
• A Pilot Study of Prostate Cancer-specific Anxiety in Active SurveillanceTerminatedNCT03227744Not applicable
• Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate CancerCompletedNCT02911350Phase 1
• Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate CancerTerminatedNCT02459912Phase 2
• MRI-Targeted Focal Ablation of the Prostate in Men With Prostate CancerCompletedNCT02303054Not applicable
• Use of PET/MRI Tracer to Further Understanding of Prostate Cancer DevelopmentCompletedNCT02106416Not applicable
• PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate CancerTerminatedNCT02042053Not applicable
• Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing SurgeryCompletedNCT02024178Not applicable
• Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.CompletedNCT01964638Not applicable
• Hypo-Fractionated Radiation Therapy for Localized Prostate CancerTerminatedNCT01677845Phase 1
• Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005048Phase 1